Preview Mode Links will not work in preview mode

Capital Allocators

Mar 30, 2020

Ben Inker is the head of the Asset Allocation team at GMO, a $60 billion asset manager known for its value bias under founder Jeremy Grantham.  Ben joined GMO right out of college nearly thirty years ago and has been there ever since.

Our conversation starts with Ben’s early investment lessons from renown economics...


Mar 23, 2020

Michael Mauboussin is the Head of Consilient Research at Counterpoint Global and fortunately, a regular guest on the show. Michael is an astute researcher of behavior, decision-making and complex systems, and I reached out to him to get his reasoned temperature on the current climate.

We discussed frameworks for making...


Mar 23, 2020

Michael Mauboussin is the well-known investment strategist currently plying his wares at Blue Mountain Capital. He joined me for the second time to discuss his new research entitled “Who’s on the Other Side?”

Our conversation dives into the work, discussing how investors can focus on process over outcome, the four...


Mar 23, 2020

Michael Mauboussin currently is the Director of Research at BlueMountain Capital, a multi-billion dollar hedge fund and asset manager. He spent the majority of his professional career thinking and writing about decision making, behavior and complex systems, with long stints at Credit Suisse and nearly a decade...


Mar 18, 2020

In the midst of this unprecedented time, I thought it would be helpful to hear from James Aitken, the extraordinary macro strategist who specializes in understanding the functioning of the financial system.

I reached out to James with one key question in mind – are we facing a systemic risk outside of what we see...